Apotex Wins Approval for DENOZA Biosimilar in Canada
TORONTO, Ontario, Canada, April 7, 2026 Apotex Inc., a leading global pharmaceutical company, announced that Health Canada has approved...
Bone Health
Advertisement
FDA Approves Accord BioPharma’s Denosumab Biosimilars, Expanding Access to Bone-Health Therapy
Durham, North Carolina, November 2025 Accord BioPharma has announced FDA approval of two denosumab biosimilars, OSVYRTI (denosumab-desu) and JUBEREQ...
Biocon Biologics Wins FDA Nod for Denosumab Biosimilars
BENGALURU, India & BRIDGEWATER, N.J. – September 17, 2025 –Biocon Biologics Ltd. (BBL), a global leader in biosimilars and...
Natural Vitamin D3 Supplement Supports Year-Round Sufficiency
FORT LAUDERDALE, September 3, 2025 – As daylight dwindles in parts of the northern hemisphere, maintaining adequate vitamin D...
Advertisement
